CompletedNCT05503498
Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration
Studying Rare hemorrhagic disorder due to a constitutional coagulation factors defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospital Clinic of Barcelona
- Principal Investigator
- ANNABEL NA BLASI, PMPHDHospital Clinic of Barcelona
- Intervention
- DATA RECORDING(other)
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2022
Study locations (2)
- Hospital Clinic, Barcelona, Spain
- Hospitla Clinic, Barcelona, Spain
Collaborators
University of Barcelona
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05503498 on ClinicalTrials.govOther trials for Rare hemorrhagic disorder due to a constitutional coagulation factors defect
Additional recruiting or active studies for the same condition.
See all trials for Rare hemorrhagic disorder due to a constitutional coagulation factors defect →